Abstract:Verrucae are benign epithelial proliferations, characteristically 1-20 mm in diameter, caused by human papilloma virus (HPV) infection occurring on the skin and mucosa (Photomed Laser Surg 33(6):338-42, 2015; Lasers Med Sci 29(3):1111-6, 2014). Prevalence of verrucae is 5-20% in children and young adults with peak incidence reported during teenage years (Lasers Med Sci 29(3):1111-6, 2014; J Am Acad Dermatol 22(4):547-66, 1990; J Korean Med Sci 24(5):889-93, 2009). Patients often express significant displeasure… Show more
“…Remarkably, PBMT at infrared wavelengths is already exploited for the treatment of viral ailments, such as the warts caused by human papillomavirus (HPV) [22], or herpetic oral lesions induced by herpes simplex virus 1 [23].…”
The study of any intervention able to counteract SARS‐CoV‐2 pandemic is considerably envisaged. It was previously shown, in in vitro models of infections, that the LED blue light is able to decrease the viral load of HSV‐1 and ZIKV. In our study, LED photobiomodulation therapy (PBMT) at blue wavelengths (450, 454 and 470 nm) was tested in an in vitro model of SARS‐CoV‐2 infection, employing three experimental settings: SARS‐CoV‐2 was irradiated and then transferred to cells; already infected cells were irradiated; cells were irradiated prior to infection. A decrement of the viral load was observed when previously infected cells were irradiated with all three tested wavelengths and relevant effects were registered especially at 48 hours post‐infection, possibly suggesting that the blue light could interfere with the intracellular viral replication machinery. Our in vitro findings could represent the starting point for translational applications of PBMT as a supportive approach to fight SARS‐CoV‐2.
“…Remarkably, PBMT at infrared wavelengths is already exploited for the treatment of viral ailments, such as the warts caused by human papillomavirus (HPV) [22], or herpetic oral lesions induced by herpes simplex virus 1 [23].…”
The study of any intervention able to counteract SARS‐CoV‐2 pandemic is considerably envisaged. It was previously shown, in in vitro models of infections, that the LED blue light is able to decrease the viral load of HSV‐1 and ZIKV. In our study, LED photobiomodulation therapy (PBMT) at blue wavelengths (450, 454 and 470 nm) was tested in an in vitro model of SARS‐CoV‐2 infection, employing three experimental settings: SARS‐CoV‐2 was irradiated and then transferred to cells; already infected cells were irradiated; cells were irradiated prior to infection. A decrement of the viral load was observed when previously infected cells were irradiated with all three tested wavelengths and relevant effects were registered especially at 48 hours post‐infection, possibly suggesting that the blue light could interfere with the intracellular viral replication machinery. Our in vitro findings could represent the starting point for translational applications of PBMT as a supportive approach to fight SARS‐CoV‐2.
“…These risks have led many physicians to opt for a wait-and-see approach, leaving patients with cosmetic insecurity and physical discomfort. Others have turned to alternative techniques such as laser therapy and oral isotretinoin, but issues over recurrent infection remain [17–19]. Evidently, there is a need for a prophylactic, nondestructive wart treatment.…”
Background: Common warts and flat warts are caused by the human papillomavirus (HPV). Peak incidence of wart infection occurs in schoolchildren aged 12-16, where prevalence can be as high as 20%. Traditional treatments aimed at destruction of wart tissue have low clearance rates and high recurrence rates. Occasional reports have even shown warts becoming malignant and progressing into verrucous carcinoma. Current licensed HPV vaccines largely target higher-risk oncogenic HPV types, but do not provide coverage of low-risk types associated with warts. To date, little attention has been given to the development of effective, anti-viral wart treatments. Objective: This study aims to identify immunodominant T-lymphocyte epitopes from the L1 major capsid protein of HPV 1, 2 and 3, a foundational step in bioengineering a peptide-based vaccine for warts. Methods: Cytotoxic T-cell and helper T-cell epitopes were predicted using an array of immunoinformatic tools against a reference panel of frequently observed MHC-I and MHC-II alleles. Predicted peptides were ranked based on IC50 and IFN-γ Inducer Scores, respectively, and top performing epitopes were synthesized and subjected to in vitro screening by IFN-γ enzyme-linked immunosorbent spot assay (ELISpot). Independent trials were conducted using PBMCs of healthy volunteers. Final chosen peptides were fused with flexible GS linkers in silico to design a novel polypeptide vaccine. Results: Seven immunodominant peptides screened from 44 predicted peptides were included in the vaccine design, selected to elicit specific immune responses across MHC class I and class II, and across HPV types. Evaluation of the vaccine′s properties suggest that the vaccine is stable, non-allergenic, and provides near complete global population coverage (>99%). Solubility prediction and rare codon analysis indicate that the DNA sequence encoding the vaccine is suitable for high level expression in Escherichia coli. Conclusions: In sum, this study demonstrates the potential and lays the framework for the development of a peptide-based vaccine against warts.
“…Extracutaneous lesions occur on orificial mucous membranes and include oral common warts, oral condylomata acuminata, focal epithelial hyperplasia, oral florid papillomatosis, nasal papillomas, conjunctival papillomas, laryngeal papillomatosis, and cervical warts 3 . Patients often express a significant reduction in quality of life due to this cosmetic nuisance, as well as functional problems and physical discomfort when they occur on the palms of the hands and soles of the feet 5 . Therefore, cutaneous warts are one of the most common pathologies treated by the clinical dermatologist 6 .…”
Section: Introductionmentioning
confidence: 99%
“…The Nd:YAG laser is preferred over other laser treatment alternatives for its deeper penetrating 1064-nm wavelength, which enables direct contact with warts while lowering the risk of pigmentation in dark skin types 5 , but is a relatively painful therapeutic option, so topical or infiltrative anesthesia is usually used 1,2,4,10,13,14 . However, direct, perilesional injections of anesthetic can lead to more local skin and tissue damage as reported by Smith 15 , and also seen firsthand at our center.…”
mentioning
confidence: 99%
“…ZORMAN ANd KORON warts. 3 Patients often express a significant reduction in quality of life due to this cosmetic nuisance, as well as functional problems and physical discomfort when they occur on the palms of the hands and soles of the feet 5 . Therefore, cutaneous warts are one of the most common pathologies treated by the clinical dermatologist 6 .…”
Background
Warts are benign epithelial proliferations that result from human papillomavirus (HPV) infection occurring on the skin and mucosa. Patients express a significant reduction in quality of life due to this cosmetic nuisance, as well as functional problems and physical discomfort. Newer methods of wart removal include different energy‐based devices, mostly lasers. Nonablative lasers such as Nd:YAG have a higher success rate and are usually used with topical or infiltrative anesthesia. The procedure may be safer without anesthesia but still tolerable with an appropriate cooling and technique.
Aims
The purpose of this study is to report on our experience over 3 years since the approach without anesthesia has been utilized.
Patients/Methods
A retrospective chart review analysis of all 85 patients who underwent 1064 nm Nd:YAG wart removal without anesthesia between November 2016 and August 2019 was conducted. One of the main outcome measures was determining the number of sessions required in order to get full clearance.
Results
The mean number of sessions was 2.2 (range 1‐7). The mean VAS pain score during the procedure was 6 (range: 2‐10), and side effects were negligible.
Conclusion
Long‐pulse 1064‐nm Nd:YAG laser without any chemical anesthesia is safe and effective for the treatment of warts.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.